Bio-Rad Laboratories, Inc.Class A vs. 908 Devices Inc. Common Stock
BIO
Bio-Rad Laboratories, Inc.Class A
$387.70 -0.57%
VS MASS908 Devices Inc. Common Stock
$10.73 -3.33%
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| BIO | MASS | |
|---|---|---|
| Market Cap | $10.37 billion | $443.51 million |
| Revenue (TTM) | $2.59 billion | $60.84 million |
| Net Income (TTM) | $222.40 million | $-34,657,000 |
BIO leads on 3 of 3 size & scale factors.
Valuation
| BIO | MASS | |
|---|---|---|
| P/E Ratio | 47.22 | — |
| Price / Book | 1.45 | 3.50 |
| Price / Sales | 4.00 | 7.29 |
BIO leads on 2 of 2 valuation factors.
Profitability
| BIO | MASS | |
|---|---|---|
| Net Margin | 8.59% | -56.96% |
| Return on Equity | 3.10% | -27.34% |
BIO leads on 2 of 2 profitability factors.
Risk & Sentiment
| BIO | MASS | |
|---|---|---|
| Short Interest | 2.44% | 0.62% |
MASS leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIO overview, BIO financials, MASS overview, MASS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.